figshare
Browse

How blood group A evolution involves reduced innate immunity and doubles the host's exposure to pathogens, as suggested by SARS-CoV-2 (COVID-19) infection. Brief communication

Download (337.1 kB)
Version 37 2025-01-13, 15:14
Version 36 2025-01-13, 12:08
Version 35 2025-01-10, 17:02
Version 34 2025-01-10, 16:36
Version 33 2025-01-09, 16:26
Version 32 2025-01-09, 11:46
Version 31 2025-01-04, 15:18
Version 30 2025-01-04, 15:04
Version 29 2024-12-28, 21:13
Version 28 2024-12-18, 11:23
Version 27 2024-12-12, 17:43
Version 26 2024-12-12, 10:25
Version 25 2024-12-12, 10:20
Version 24 2024-12-11, 17:24
Version 23 2024-12-11, 17:20
Version 22 2024-12-11, 17:15
Version 21 2024-12-11, 17:10
Version 20 2024-12-11, 17:05
Version 19 2024-12-11, 16:59
Version 18 2024-12-11, 11:03
preprint
posted on 2025-01-13, 15:14 authored by Peter ArendPeter Arend

The formation of evolutionary hybrid Tn (T “nouvelle”) cross-reactive A antigens, together with glycosylations on cell surfaces and plasma proteins, and the generation of mucin-type A- and B allele-connected hybrid epitopes, doubles the host's exposure to pathogens by two genetically distinct bindings, neutralising the innate anti-Tn/A reactivities of pre-existing polyreactive IgM. This consequent protection against A-phenotypic autoimmunity implies a reduction in innate immunity, which explains the increased susceptibility and severity of disease in blood group A individuals.


History

Usage metrics

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC